NDC 63323-574
Icatibant
Icatibant
Icatibant is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Fresenius Kabi Usa, Llc. The primary component is Icatibant Acetate.
| Product ID | 63323-574_a9f19a4a-ee09-4185-b8ea-27ac98b92b47 |
| NDC | 63323-574 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Icatibant |
| Generic Name | Icatibant |
| Dosage Form | Injection, Solution |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2020-11-15 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA208317 |
| Labeler Name | Fresenius Kabi USA, LLC |
| Substance Name | ICATIBANT ACETATE |
| Active Ingredient Strength | 10 mg/mL |
| Pharm Classes | Bradykinin B2 Receptor Antagonist [EPC],Bradykinin B2 Receptor Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |